Thermo Fisher Scientific Acquires Proteomics Workflow Solution Provider, Proxeon

WALTHAM, Mass. (April 15, 2010) – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark. The company is recognized for its ability to provide a simplified proteomics workflow, including nanoflow liquid chromatography systems, columns, ion sources, and bioinformatics software, to meet the need for robust high-sensitivity liquid chromatography/mass spectrometry (LC/MS) analysis in complex proteomics applications. Proxeon had revenues of approximately $10 million in 2009 and has nearly 40 employees.

Proxeon aims to boost productivity in proteomics labs - launches EASY-nLC II for LC-MS

Proxeon announced today the release of the company's second generation instrument, EASY-nLC™ II, optimized for LC-MS applications in proteomics and providing scientists with the opportunity to significantly improve system productivity as a result of a new autosampler and upgraded software.

Proxeon expands commercial operations in Europe and Asia-Pacific

Proxeon confirmed today that the company is significantly expanding its sales and marketing network in Europe and Asia-Pacific, having signed six new distribution agreements.

Investigation confirms need for better data interpretation tools in MS-based proteomics

The need for an efficient and reliable data interpretation tool was highlighted in a recent publication in which the authors concluded: "Most notably, we found generic problems in databases to be the major hurdle for the correct characterization of proteins in the test sample." [A HUPO test sample study reveals common problems in mass spectrometry-based proteomics, Nature Methods (6, 423-430 2009)]

EASY-nLC enables discovery of oldest protein sequences ever acquired

Odense, Denmark, 05 May 2009. Proxeon's EASY-nLC, together with a Thermo Orbitrap XL, has been used to successfully analyze ancient protein dating back 80 million years. The LC-MS set-up, situated in the laboratory of Dr.John Asara, Director of the Mass Spectrometry Core at Beth Israel Deaconess Medical Center (BIDMC), has provided new evidence to support the concept of protein preservation across geological time and to suggest that birds and dinosaurs are evolutionarily related.

Proxeon ion sources achieve C.S.I. standards

Odense, Denmark, 23 March 2009. Proxeon ion sources have been well-regarded by users and mass spectrometer suppliers for many years. But, in November last year, they began to reach a new audience - millions of viewers watching the American CBS crime series C.S.I.: Miami.

Proxeon expands ProteinCenter functionality

Odense, Denmark, 10 March 2009. Proxeon today announced the addition of new functionalities to ProteinCenter^TM, the company's unique proteomics data interpretation tool that bridges the gap between search engine and publications. ProteinCenter rapidly interprets complex datasets into biologically-relevant information.

Proxeon expands commercial operations - confirms key appointments

Odense, Denmark, 18 February 2009. Proxeon confirmed today the expansion of the company's commercial operations through several key appointments.

Proxeon A/S completes financing round alongside successful 2008 sales

Odense, Denmark, 2 February 2009. Proxeon A/S (Proxeon) today announced that it has successfully completed a capital increase of DKK 14 Million. The investment was made by current venture capital investors as well as several members of the board.

University of Washington Proteomics Resource Center gets access to Proxeon's ProteinCenter

UWPR facility's mission is to advance proteomics technologies

Odense, Denmark, 15 December 2008. Proxeon today announced a partnership with the University of Washington Proteomics Resource Center (UWPR), Seattle that gives UWPR researchers access to the company's ProteinCenter^TM, the unique data interpretation tool that converts complex proteomics datasets into biological sense.